Similarly, although screening procedures exist for breast cancer and head and neck squamous cell carcinoma, the high overexpression of oncofetal FN in stage I tumors presents a potential ECM marker to exploit for supplementing current clinical screening procedures and improving early detection of disease. Here, FN1 is linked to breast cancer.